Journal ArticleOPEN ACCESS

Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: A promising treatment

American Journal of Hematology (2001) 66(3) 224-226
DOI: 10.1002/1096-8652(200103)66:3<224::AID-AJH1049>3.0.CO;2-E
10Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion. © 2001 Wiley-Liss, Inc.

Author supplied keywords

Cite

CITATION STYLE

APA

Hirawat, S., Lichtman, S. M., & Allen, S. L. (2001). Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: A promising treatment. American Journal of Hematology, 66(3), 224–226. https://doi.org/10.1002/1096-8652(200103)66:3<224::AID-AJH1049>3.0.CO;2-E

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free